Hong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales

Tianjin Development Holdings

28/08/2026 10:57

Overview
Hong Kong conglomerate's interim revenue for six months ended June 2026 declined yr/yr
Net income attributable to owners of the company fell compared to prior yr period
Interim dividend maintained at HK$0.0518 per share, unchanged from prior yr

Outlook
Company did not provide specific financial guidance or outlook for future periods

Result Drivers
HEAT & POWER REVENUE DECLINE - Company said revenue from the Heat & Power Company decreased mainly due to lower government supplemental income and lower steam sales volume
ASSOCIATES' PROFIT GROWTH – Share of associate and joint-venture profit rose to HK$292.5 mln from HK$249.3 mln, led by higher contributions from Tianjin Port and TEDA Power
PHARMACEUTICAL SALES DECLINE - Company said pharmaceutical segment revenue decreased 6.0% year-on-year
UTILITY VOLUME PRESSURE – Water profit fell 15.5% as water sales volume declined 4% and ancillary-services income decreased

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
HK$1.66 bln
 
H1 Net Income Attributable
 
HK$325.20 mln
 

Reuters Recommended Reads
Aug 27 - Hong Kong's China Everbright H1 net loss widens as litigation charges weigh in
Aug 27 - Hong Kong's Shanghai Industrial H1 profit rises on lower real estate impairment
Aug 27 - Hong Kong's Founder Holdings half-year revenue edges lower

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)